Correvio Pharma (CORV) Tops Q4 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. GS
4. UNH
5. ORCL
6. AVAV
7. BAC
8. DVLT
9. LQDA
10. ACI

Go back to Correvio Pharma (CORV) Tops Q4 EPS by 3c, Revenues Beat

Correvio Reports Fourth Quarter and Full Year 2018 Financial Results

March 13, 2019 7:00 AM EDT

Company on Track to Resubmit Brinavess NDA in Q2 2019

Mark H.N. Corrigan, MD to Commence CEO Duties on March 14, 2019

Management to Host Conference Call and Webcast Today, March 13, 2019 at 8:00 a.m. Eastern (5:00 a.m. Pacific)

NASDAQ: CORV  TSX: CORV

VANCOUVER, March 13, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today reported financial results for its fourth quarter and year ended December 31, 2018 and commented on recent... More